---
title: "CSPC Wins Shareholder Approval for Disposal of 30% Stake in Beijing Guoxin Huijin"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282062275.md"
description: "CSPC Wins Shareholder Approval for Disposal of 30% Stake in Beijing Guoxin Huijin"
datetime: "2026-04-08T14:59:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282062275.md)
  - [en](https://longbridge.com/en/news/282062275.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282062275.md)
---

# CSPC Wins Shareholder Approval for Disposal of 30% Stake in Beijing Guoxin Huijin

CSPC Wins Shareholder Approval for Disposal of 30% Stake in Beijing Guoxin Huijin

### Related Stocks

- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [520500.CN](https://longbridge.com/en/quote/520500.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)

## Related News & Research

- [CSPC Innovation Posts Strong Revenue Growth but Wider Losses in Q1 2026](https://longbridge.com/en/news/284213122.md)
- [Junshi Biosciences Shareholder Plans Up to 2% Stake Reduction](https://longbridge.com/en/news/283841816.md)
- [GenFleet Asserts Independent IP for Pan RAS Inhibitor GFH276 Amid Sector Dispute](https://longbridge.com/en/news/284312081.md)
- [Everest Medicines Announces Positive First-in-Human Data for Personalized mRNA Cancer Vaccine EVM16 at AACR 2026](https://longbridge.com/en/news/283616571.md)
- [TransThera Raises HK$282 Million via H-Share Placing to Fund Cancer Drug Push](https://longbridge.com/en/news/283489861.md)